ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $766,081 | -11.9% | 28,227 | -0.2% | 0.01% | -7.7% |
| Q2 2023 | $869,665 | -14.7% | 28,291 | 0.0% | 0.01% | -27.8% |
| Q1 2023 | $1,019,325 | +17.7% | 28,291 | +29.1% | 0.02% | 0.0% |
| Q4 2022 | $866,041 | -1.7% | 21,914 | 0.0% | 0.02% | -10.0% |
| Q3 2022 | $881,000 | +8.9% | 21,914 | +13.8% | 0.02% | +5.3% |
| Q2 2022 | $809,000 | +7.9% | 19,249 | 0.0% | 0.02% | +18.8% |
| Q1 2022 | $750,000 | -2.2% | 19,249 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $767,000 | +164.5% | 19,249 | +139.6% | 0.02% | +128.6% |
| Q3 2021 | $290,000 | -12.4% | 8,033 | -0.7% | 0.01% | -12.5% |
| Q2 2021 | $331,000 | -6.0% | 8,087 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $352,000 | +10.7% | 8,087 | +27.2% | 0.01% | 0.0% |
| Q4 2020 | $318,000 | – | 6,356 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |